FR EA

Extract to table

Pull the structured facts out of a document: parties, dates, amounts, obligations.

Extract to table / lock-up-waiver-analysis-memo.docx
lock-up-waiver-analysis-memo.docx · 1018-00001

Parties

Penterra Pharmaceuticals Corp
Ridgeline Securities LLC
Broadmark Capital Inc
Castellano Family Holdings LLC
Harborview Partners LLC
Harkness LLP
Cascade Biosciences Corp
Strauss LLP

Dates

September 14, 2023
April 17, 2023
October 14, 2023
October 12, 2023
April 12, 2023
August 22, 2023
September 15, 2023
September 18, 2023
September 29, 2023
October 2, 2023

Amounts

$260,000,000
$22.00
$528,000,000
$41.60

Obligations

Each firm's consent must be separately obtained and evidenced in writing
We assess the risk of Morningstar Zanthor withholding consent as low, but it is the primary risk to the transaction timeline and must be managed proactively
The Notice Provision The IPO Lock-Up Agreements contain a provision requiring that, in the event any of the IPO Underwriters grants an early release or waiver of the lock-up restrictions, the IPO Underwriters shall provide at least 14 calendar days' advance notice to PPC and to the affected Lock-Up Parties prior to the effective date of any such early release or waiver
Prospectus Supplement Disclosure The fact that the Selling Stockholders' shares are being sold pursuant to a lock-up waiver must be clearly and prominently disclosed in the prospectus supplement for the Secondary Offering
Sales of PPC common stock by Section 16 insiders must be reported on Form 4, filed with the SEC no later than two business days following the date of the transaction
Nonetheless, this risk must be proactively managed through early outreach and direct engagement at the partner level